|1||NCT01830153||Completed||RAD001 in Advanced Sarcoma||
||Other / Industry||
||41||All||17 Years and older (Child, Adult, Senior)||NCT01830153||CRAD001CKR13T||April 2010||January 2013||April 12, 2013||April 12, 2013||
|RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib||
||416||All||18 Years to 85 Years (Adult, Senior)||NCT00410124||CRAD001C2240
|RECORD-1||November 2006||February 2008||October 2011||December 12, 2006||January 15, 2013||January 15, 2013||
† Study has passed its completion date and status has not been verified in more than two years.